Aimia Inc. AIM

Aimia Inc. (TSX: AIM) (JSE: AII) (AIM: AII) ("the Company") is pleased to announce the admission of its common shares to trading on the AIM market of the London Stock Exchange, and dealings will commence today at 8:00am BST under the ticker symbol "AII" (ISIN: CA00900Q1037; SEDOL: B84YZ75).

Aimia Inc. (TSX: AIM) (JSE: AII) ("the Company") today announced that it has made an application for the admission of its common shares to trading on the London Stock Exchange's AIM Market ("AIM"). Subject to the receipt of necessary approvals, Aimia anticipates trading on AIM will commence on or about September 9, 2026. Aimia will trade under the symbol "AII."

Aimia (TSE:AIM) reported a second-quarter marked by the sale of Bozzetto, higher net book value per share and steps to reduce debt costs, while management said it expects improving conditions at its Cortland rope and netting business in the second half of 2026. Executive Chairman Rhys Summerton sai

Management outlines a disciplined capital deployment strategy focused on undervalued targets and Courtland's operational resilience.

Aimia Inc. (TSX: AIM) (JSE: AII) will announce its second quarter 2026 financial results for the period ended June 30, 2026 on Tuesday, August 11, 2026.

Aimia Inc. (TSX: AIM) (JSE: AII) announced today that it repurchased and settled for cancellation a total of 174,750 of its common shares in the month of July 2026 under the Company's normal course issuer bid program ("NCIB"). The total represents 0.2% of Aimia's 88,225,735 common shares outstanding as at July 31, 2026.

Aimia Inc. (TSX: AIM) (JSE: AII) ("the Company") today announced the expiration and results of its previously disclosed tender offer ("Offer") to purchase for cash any and all of its outstanding 9.75% Senior Unsecured Notes ("Senior Notes") with an aggregate principal amount of $142.6 million due in 2030.

Aimia Inc. (TSX: AIM) (JSE: AII) ("Aimia" or the "Company") announces that the Toronto Stock Exchange (the "TSX") has approved its previously-announced normal course issuer bid ("NCIB").

Aimia Inc. (TSX: AIM) (JSE: AII) announced today that it repurchased and settled for cancellation a total of 224,400 of its common shares in the month of May 2026 under the Company's normal course issuer bid program ("NCIB"). The total represents 0.25% of Aimia's 88,565,885 common shares outstanding as at May 31, 2026.

Aimia Inc. (TSX: AIM) (JSE: AII) ("the Company") today confirmed the closing of its previously announced sale of its interest in Giovanni Bozzetto S.p.A ("Bozzetto") for net proceeds of CAD$268.4 million.

Aimia Inc. (TSX: AIM) (JSE: AII) announced today that all five nominees proposed for election to the Company's Board of Directors listed in its management information circular dated April 8, 2026 were elected at its Annual Meeting of Shareholders. The percentage of shares at the Meeting voting in favour of individual directors is as follows:

Aimia Inc (AIMFF) reports improved net earnings and strategic moves, despite challenges in its Courtland business.

On Wednesday, Aimia (TSX:AIM) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. Access the full call at https://app.webinar.net/EPYVWBVW2wk Summary AIM ImmunoTech Inc announced the divestiture of its specialty chemicals business, Bazzetto, and received regulatory approvals for the t

Aimia Inc. (TSX: AIM) (JSE: AII) ("Aimia" or the "Company"), today reported its financial results for the three months ended March 31, 2026. All amounts are in Canadian currency unless otherwise noted.